Beneficial gut microbes and the body work together to fine-tune fat metabolism and cholesterol levels, according to a new preclinical study by investigators from Weill Cornell Medicine and the Boyce Thompson Institute at Cornell University’s Ithaca campus.
Lilly’s £279m bet aims to boost UK life sciences sector
Leading obesity drugmaker Lilly has announced a £279m ($365.5m) investment in the UK in a major collaboration between the company and the UK government. The